Axsome Logo.png
Axsome Therapeutics to Host Sunosi® Investor Update Virtual Event
June 22, 2022 07:00 ET | Axsome Therapeutics, Inc.
NEW YORK, June 22, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous...
Axsome Logo.png
Axsome Therapeutics to Acquire Sunosi® from Jazz Pharmaceuticals, Expanding Axsome’s Leadership in Neuroscience
March 28, 2022 06:00 ET | Axsome Therapeutics, Inc.
Sunosi is the first and only dual-acting dopamine and norepinephrine reuptake inhibitor (DNRI) approved by the FDA to improve wakefulness in adults living with excessive daytime sleepiness associated...
respirerx.jpg
RespireRx Pharmaceuticals Inc. Announces Patent Filings Claiming Novel Lipid Based Formulations for Insoluble Compounds, Including Cannabinoids Such as Dronabinol
March 23, 2022 08:00 ET | RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., March 23, 2022 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQ:RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...
respirerx.jpg
Letter to Stockholders and Other Stakeholders: A Brief Summary of Our Progress During Past Twelve Months and a Peek Looking Forward
March 07, 2022 08:00 ET | RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., March 07, 2022 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQ:RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...
respirerx.jpg
RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO 
November 04, 2021 08:45 ET | RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., Nov. 04, 2021 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI), (“RespireRx” or the “Company”) a leader in the discovery and development of innovative and...
Luminate.png
Luminate NY Announces The Optical Society to Sponsor Finals 2021 Competition
August 26, 2021 09:00 ET | Luminate
ROCHESTER, N.Y., Aug. 26, 2021 (GLOBE NEWSWIRE) -- Luminate NY, the world's largest accelerator for startups with optics, photonics, and imaging(OPI) enabled applications, announced today that The...
respirerx.jpg
RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split
January 05, 2021 16:05 ET | RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company” or “we”), has, on January 4, 2021, filed with the Secretary of State of...
Sundensity's Photonic Smart Coating Enhances Energy Output of Solar Panels by 20%
Governor Cuomo Announces Round 3 Winners of Luminate NY Accelerator Competition in Rochester
September 14, 2020 16:30 ET | Luminate
SunDensity Awarded Top Honors and $1 Million in Investment Four Additional Visionary Optics, Photonics, and Imaging Companies Secure Follow-on Funding Investment Applications Now Being Accepted for...
OvitzMillionWinner2019
Luminate NY to Hold Innovation Finals Competition at OSA’s FiO + LS Conference
August 11, 2020 09:00 ET | Luminate
ROCHESTER, N.Y., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Luminate NY, the world's largest accelerator for startups with next-generation optics, photonics, and imaging (OPI) enabled applications, will host...
respirerx.jpg
RespireRx Pharmaceuticals Inc. Announces Extension to Long-Term Employment Contract with Tim Jones as President and Chief Executive Officer
August 03, 2020 15:11 ET | RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., Aug. 03, 2020 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC: RSPI) (“RespireRx” or the “Company”), is pleased to announce that today, Mr. Tim Jones and RespireRx have...